UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
one):
☐
Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR
For
Period Ended: March 31, 2021
☐
Transition Report on Form 10-K
☐
Transition Report on Form 20-F
☐
Transition Report on Form 11-K
☐
Transition Report on Form 10-Q
☐
Transition Report on Form N-SAR
For
the Transition Period Ended: _________
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I - REGISTRANT INFORMATION
BOQI
International Medical Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-50155
|
|
02-0563302
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission File Number)
|
|
(IRS
Employer
Identification
No.)
|
Room
3601, Building A, Harbour View Place, No. 2 Wuwu Road,
Zhongshan
District, Dalian, Liaoning Province, P. R. China, 116000
(8604)
1182209211
(Address,
including zip code, and telephone number, including area code, of registrant's principal executive offices)
PART
II - RULES 12b-25 (b) AND (c)
If
the subject report could not be filed without reasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
☒
(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or
expense;
☒
(b) The subject annual report, semi-annual report, transition report on Form10-K, Form 20-F,Form11-K, Form N-SAR or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and
☐
(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART
III – NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not
be filed within the prescribed time period.
The
Registrant has encountered certain logistical delays in finalizing the financial information for the period ended March 31, 2021. Accordingly,
the timely filing of the Form 10-Q has become impracticable without undue hardship and expense to the Registrant. The Company undertakes
the responsibility to file such report no later than five days after its original prescribed due date.
PART
IV - OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification:
Pang
Zhang-Whitaker, Esq., 212.238.8844
(2)
Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment
Company act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If the answer is no, identify report(s).
☒
Yes ☐ No
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
☒
Yes ☐ No
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
The
Registrant expects to report revenues of approximately $2 million for the first three months of 2021 as compared to revenues of $414,584
for the same period in 2020. The Registrant expects that it will report a net loss of approximately $3.8 million for the first three
months of 2021 as compared to net loss of $2,194,875 for the same period in 2020.
The
Registrant has caused this notification to be signed on its behalf by the undersigned, hereunto duly authorized.
BOQI International Medical Inc.
|
|
(Registrant)
|
|
|
|
|
By:
|
/s/ Tiewei Song
|
|
|
Tiewei Song
|
|
|
Chief Executive Officer
|
|
|
Dated: May 18, 2021
|
|
3
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Apr 2023 to Apr 2024